Construction and hemocompatibility study of highly bioactive heparin-functionalized surface

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 11, 2012, Pages 3124-3133

  Yang, Zhi Lu ^a   Zhou, Shuo ^a   Lu, Lei ^a   Wang, Xin ^a   Wang, Jin ^a   Huang, Nan ^a  

^a SOUTHWEST JIAOTONG UNIVERSITY   (China)

Author keywords

Biological activity; Hemocompatibility; Heparin; Passive adsorption; Protonated functionality

Indexed keywords

ADSORPTION; BIOACTIVITY; PROTONATION; SURFACE TREATMENT;

316 L STAINLESS STEEL; ACTIVATED PARTIAL THROMBOPLASTIN TIME; ADSORPTION AMOUNTS; ALLYL AMINE; BLOOD PLATELET ADHESIONS; HEMOCOMPATIBILITY; HEPARIN; HIGH AFFINITY; LONG-TERM IMMERSIONS; PHOSPHATE-BUFFERED SALINES; PROTONATED; SIMPLE METHOD;

POLYSACCHARIDES;

ALLYLAMINE; ANTITHROMBIN III; FIBRINOGEN; HEPARIN; PHOSPHATE BUFFERED SALINE; PLASMA POLYMERIZED ALLYLAMINE; STAINLESS STEEL; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; BINDING AFFINITY; BIOCOMPATIBILITY; CELL STRUCTURE; COVALENT BOND; HUMAN; HUMAN CELL; PARTIAL THROMBOPLASTIN TIME; POLYMERIZATION; PROTEIN IMMOBILIZATION; PROTON TRANSPORT; SCANNING ELECTRON MICROSCOPY; STATIC ELECTRICITY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION;

EID: 84869094948     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34247     Document Type: Article

References (35)

1. Vrolix MC, Legrand VM, Reiber JHC, Grollier G, Schalij MJ, Brunel P, Martinez-Elbal L, Gomez-Recio M, Bär FW, Bertrand ME, Colombo A, Brachman J. Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). Am J Cardiol 2000;86:385-389. (Pubitemid 30628602)
2. Kim YJ, Kang IK, Huh MW, Yoon SC. Surface characterization and in vitro blood compatibility of poly (ethylene terephthalate) immobilized with insulin and/or heparin using plasma glow discharge. Biomaterials 2000;21:21-30.
3. Chen H, Chen Y, Sheardown H, Brook MA. Immobilization of heparin on a silicone surface through a heterobifunctional PEG spacer. Biomaterials 2005;26:7418-7424. (Pubitemid 41133593)
4. Wissink MJ, Beernink R, Pieper JS, Poot AA, Engbers GH, Beugeling T, van Aken WG, Feijen J. Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. Biomaterials 2001;22:151-163.
5. Albanese A, Barbucci R, Belleville J, Bowry S, Eloy R, Lemke HD, Sabatini L. In vitro biocompatibility evaluation of a heparinizable material (PUPA), based on polyurethane and poly (amido-Amine) components. Biomaterials 1994;15:129-136.
6. Meng S, Liu ZJ, Shen L, Zhang G, Chou LL, Zhong W, Du QG, Ge JB. The effect of a layerby-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials 2009;30:2276-2283.
7. Fu JH, Ji J, Yuan WY, Shen JC. Construction of anti-Adhesive and antibacterial multilayer films via layer-by-layer assembly of heparin and chitosan. Biomaterials 2005;26:6684-6692. (Pubitemid 41021761)
8. Huang XJ, Guduru D, Xu ZK, Vienken J, Groth T. Blood compatibility and permeability of heparin-modified polysulfone as potential membrane for simultaneous hemodialysis and LDL removal. Macromol Biosci 2010;10:131-140.
9. Gong FR, Cheng XY, Wang SF, Zhao YC, Gao Y, Cai HB. Heparinimmobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents. Acta Biomaterialia 2010;6:534-546.
10. Li GC, Yang P, Qin W, Maitz MF, Zhou S, Huang N. The effect of coimmobilizing heparin and fibronectin on titanium on hemocompatibility and endothelialization. Biomaterials 2011;32:4691-4703.
11. Decher G. Fuzzy nanoassemblies: Toward layered polymeric multicomposites. Science 1997;277:1232-1237. (Pubitemid 27449063)
12. Patil SD, Papadmitrakopoulos F, Burgess DJ. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release 2007;117:68-79. (Pubitemid 46164863)
13. Liu Q, Ding J, Mante FK, Wunder S, Baran GR. The role of surface functional groups in calcium phosphate nucleation on titanium foil: A self-Assembled monolayer technique. Biomaterials 2002;23:3103-3111. (Pubitemid 34522123)
14. Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed 2002;41:391-412.
15. Hamerli P, Weigel T, Groth T, Paul D. Surface properties of and cell adhesion onto allylamine-plasma-coated polyethylenterephtalat membranes. Biomaterials 2003;24:3989-3999. (Pubitemid 36798120)
16. 2 coating for covalent immobilization of heparin. Plasma Process Polym 2011;8:850-858.
17. Truica-Marasescu F, Wertheimer MR. Nitrogen-rich plasmapolymer films for biomedical applications. Plasma Process Polym 2008;5:44-57.
18. Puleo DA, Kissling RA, Sheu MS. A technique to immobilize bioactive proteins, includingbone morphogenetic protein-4 (BMP-4), on titanium alloy. Biomaterials 2002;23:2079-2087. (Pubitemid 34251082)
19. Yang ZL, Lei XJ, Wang J, Luo RF, He TT, Sun H, Huang N. A novel technique toward bipolar films containing alternating nanolayers of allylamine and acrylic acid plasma polymers for biomedical application. Plasma Process Polym 2011;8:208-214.
20. Yang ZL, Wang XN, Wang J, Yao Y, Sun H, Huang N. Pulsedplasma polymeric allylamine thin films. Plasma Process Polym 2009;6:498-505.
21. Yang ZL, Wang J, Luo RF, Maitz MF, Jing FJ, Sun H, Huang N. The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility. Biomaterials 2010;31:2072-2083.
22. Yang ZL, Tu QF, Wang J, Lei XJ, He TT, Sun H, Huang N. Bioactive plasma-polymerized bipolar films for enhanced endothelial cell mobility. Macromol Biosci 2011;11:797-805.
23. Chandler AB. In vitro thrombotic coagulation of the blood. A method for producing a thrombus. Lab Invest 1958;7:110-114.
24. Muir BW, Nelson A, Fairbrother A, Fong C, Hartley PG, James M, McLean KM. A comparative X-ray and neutron reflectometry study of plasma polymer films containing reactive amines. Plasma Process Polym 2007;4:433-444. (Pubitemid 46902315)
25. Nuner GL, Thomas CN, Hanson SR, Barry JJ, King SB, Andreas R. Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogelcoated balloon. NAS Circ 1995;92:1697-1700.
26. Spanos CG, Badyal JPS, Goodwin AJ, Merlin PJ. Pulsed plasmachemical deposition of polymeric salt networks. Polymer 2005;46:8908-8912. (Pubitemid 41328569)
27. Truica-Marasescu F, Wertheimer MR. Nitrogen-rich plasmapolymer films for biomedical applications. Plasma Process Polym 2008;5:44-57
28. Lawrie G, Keen I, Drew B, Chandler-Temple A, Rintoul L, Fredericks P, Lisbeth Grøndahl. Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS. Biomacromolecules 2007;8:2533-2541. (Pubitemid 47316995)
29. Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973;248:6490-6505.
30. Wootton DM, Ku DN. Fluid mechanics of vascular systems, diseases, and thrombosis. Annu Rev Biomed Eng 1999;1:299-329. (Pubitemid 129740014)
31. Davie EW, Fujikawa K. Basic mechanisms in blood coagulation. Annu Rev Biochem 1975;44:799-829.
32. Wu KK. Platelet activation mechanisms and markers in arterial thrombosis. J Intern Med 1996;239:17-34. (Pubitemid 26022569)
33. Barbucci R, Lamponia S, Aloisi AM. Platelet adhesion to commercial and modified polymer materials in animals under psychological stress and in a no-stress condition. Biomaterials 2002;23:1967-1973. (Pubitemid 34251070)
34. McEver RP, Martin NM. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984;259:9799-9804. (Pubitemid 14058590)
35. Nieuwenhuis HK, van Ouosterhout JJG, Rozemuller E, van Iwaarden F, Sixma JJ. Studies with a monoclonal antibody against activated platelets. Blood 1987;70:838-845.